Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:collaboratedWith |
gptkb:Takeda_Pharmaceutical_Company
|
| gptkbp:defunct |
2014
|
| gptkbp:focus |
therapeutics for kidney disease
|
| gptkbp:foundedIn |
1988
|
| gptkbp:founder |
gptkb:Stephen_Fodor
Aleksandr Levitzki |
| gptkbp:headquartersLocation |
gptkb:Palo_Alto,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Affymax, Inc.
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:keyPerson |
John Orwin
|
| gptkbp:notableProduct |
gptkb:Omontys
|
| gptkbp:status |
defunct
|
| gptkbp:tradedOn |
gptkb:NASDAQ:_AFFY
|
| gptkbp:website |
www.affymax.com
|
| gptkbp:bfsParent |
gptkb:NASDAQ:_AFFY
|
| gptkbp:bfsLayer |
8
|